+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Pruritus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 192 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2025

  • Report
  • November 2025
  • 500 Pages
  • Global
From
Dermatological Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatological Drugs - Global Strategic Business Report

  • Report
  • December 2025
  • 422 Pages
  • Global
From
From
From
Acute Myeloid Leukemia Market Report 2025 - Product Thumbnail Image

Acute Myeloid Leukemia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Myelodysplastic Syndrome Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Live Attenuated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report

  • Report
  • December 2025
  • 563 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • December 2025
  • 367 Pages
  • Global
From
Tetanus Toxoid Vaccine - Global Strategic Business Report - Product Thumbnail Image

Tetanus Toxoid Vaccine - Global Strategic Business Report

  • Report
  • December 2025
  • 265 Pages
  • Global
From
Toxoid Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines Market - Global Strategic Business Report

  • Report
  • December 2025
  • 282 Pages
  • Global
From
Polio Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Polio Vaccines Market - Global Strategic Business Report

  • Report
  • December 2025
  • 277 Pages
  • Global
From
Inactivated Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Inactivated Vaccines Market - Global Strategic Business Report

  • Report
  • December 2025
  • 468 Pages
  • Global
From
DNA Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines Market - Global Strategic Business Report

  • Report
  • December 2025
  • 171 Pages
  • Global
From
Bacterial Vaccines Market - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines Market - Global Strategic Business Report

  • Report
  • December 2025
  • 490 Pages
  • Global
From
Loading Indicator